Tech Company Financing Transactions
Genalyte Funding Round
Genalyte, based in San Diego, secured $11.8 million from Claremont Creek Ventures and private investors.
Transaction Overview
Company Name
Announced On
3/31/2012
Transaction Type
Venture Equity
Amount
$11,800,000
Round
Series B
Investors
Proceeds Purpose
Genalyte intends to use the new funds primarily for commercialization of its Maverick(TM) platform and its highly multiplexed panels for autoimmune and immunoassay applications.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
10520 Wateridge Cir.
San Diego, CA 92121
USA
San Diego, CA 92121
USA
Phone
Website
Email Address
Overview
At Genalyte, Inc. Results Matter, Now. Bringing the doctor, the patient and test results together when they matter most.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Cary Gunn
Chief Marketing Officer
Rick Hockett
Vice President
Sasi Mudumba
VP - Manufacturing
Aaron Hanson
VP - Product Management
Michael O'Neil
VP - Sales
Rob Kelley
Browse more venture capital transactions:
Prev: 3/31/2012: Securus Medical Group venture capital transaction
Next: 3/31/2012: ComQi venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to report on funding rounds that are announced publicly. All VC database entries reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs